What diseases does ramucirumab (ramucirumab) treat? Indications

Ramucirumab (ramucirumab) is used alone or with paclitaxel to treat advanced or metastatic (cancer that has spread) stomach or gastroesophageal junction cancer (GEJ) after patients have received other cancer drugs that have not responded well, such as those containing fluoropyrimidines or platinum. Ramucirumab injection is also used with erlotinib for the first-line treatment of patients with metastatic (cancer that has spread) non-small cell lung cancer who have certain types of abnormal epidermal growth factor receptor (EGFR) genes (exon 19deletions or exon 21mutations). Ramucirumab injection is also used in combination with docetaxel to treat metastatic (cancer that has spread) non-small cell lung cancer in patients receiving other cancer drugs, such as platinum-based drugs. The drug is used in patients whose tumors contain abnormal EGFR or ALK genes, and who have tried treatments for those tumors without success. RamucirumabInjection is also combined with leucovorin, 5-fluorouracil and irinotecan (FOLFIRI) For the treatment of metastatic colorectal cancer (cancer that has spread) that has not responded well to other cancer drugs (such as bevacizumab, oxaliplatin, or drugs containing fluoropyrimidine) (mCRC). RamucirumabInjection is also used to treat a type of liver cancer called hepatocellular carcinoma (HCC) in patients treated with other drugs, such as sorafenib. This medication should only be taken under the direct supervision of a doctor. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.